Skip navigation

Nzomics Biocatalysis

Nzomics develops novel enzymes for clients in the pharmaceutical, chemical, biofuel and food sectors. Using an enzyme alternative for a chemical process is cost-effective, efficient and environmentally sound.

Our research and development focus is to develop novel intellectual property for our client using state-of-the-art chemistry, molecular biology and biotechnology.

Our approach to novelty and variety in industrial enzymes
With the advent of genome sequencing and the invention of molecular biology tools which enable the translation of primary amino acid sequence from a public database to pure expression in a cell factory in a matter of weeks, enzyme technology has come of age as a viable solution to many chemical problems. Compared with the obvious processing methods of using a biodegradable reagent free from precious or polluting metals, enzyme-based methods are often more selective with obvious benefits in terms of cost of processing and purification.

Additionally, companies which own the enzymes (rather than rely on a supplier) for their key processes have security of supply over what might be the key component in a vital manufacturing route.

For more information about us and some of our clients please visit our website: http://nzomicsbiocatalysis.co.uk

 


Latest News and Features

Dr Monika Winter and Dr Emily Hume from Northumbria University are among 62 researchers from across the UK to be chosen to receive funding in recognition of their pioneering approaches to improve human health and wellbeing.
Northumbria University News Spring 2025
Fruit flies
The Lit & Phil, Newcastle. Image by Sally Ann Norman
Student working in lab environment
Image of mother and baby
General Secretary of the Microbiology Society, Professor Karen Robinson, presents Dr Helen Hooper and Dr Amanda Jones from Northumbria University with the 2024 Microbiology Society Outreach Prize.
plastic bottles

Back to top